2010
DOI: 10.1186/1742-4690-7-45
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Prototype Foamy Virus particle-host cell interaction with autofluorescent retroviral particles

Abstract: BackgroundThe foamy virus (FV) replication cycle displays several unique features, which set them apart from orthoretroviruses. First, like other B/D type orthoretroviruses, FV capsids preassemble at the centrosome, but more similar to hepadnaviruses, FV budding is strictly dependent on cognate viral glycoprotein coexpression. Second, the unusually broad host range of FV is thought to be due to use of a very common entry receptor present on host cell plasma membranes, because all cell lines tested in vitro so … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

5
98
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 63 publications
(103 citation statements)
references
References 57 publications
5
98
0
Order By: Relevance
“…A 4-component PFV vector system consisting of the expression vectors pcoPG4 (PFV Gag), pcoPE (PFV Env), pcoPP or pcziPol, (PFV Pol), and the enhanced green fluorescent protein (eGFP)-expressing PFV transfer vector pMD9 has been described previously (20,33,50). Due to biosafety issues, a previously described variant PFV Pol expression construct with catalytically inactive reverse transcriptase, pcoPP2 (Pol iRT) (32,33), was used for live-cell imaging experiments employing the 4-component PFV vector system.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A 4-component PFV vector system consisting of the expression vectors pcoPG4 (PFV Gag), pcoPE (PFV Env), pcoPP or pcziPol, (PFV Pol), and the enhanced green fluorescent protein (eGFP)-expressing PFV transfer vector pMD9 has been described previously (20,33,50). Due to biosafety issues, a previously described variant PFV Pol expression construct with catalytically inactive reverse transcriptase, pcoPP2 (Pol iRT) (32,33), was used for live-cell imaging experiments employing the 4-component PFV vector system.…”
Section: Methodsmentioning
confidence: 99%
“…Additionally, the original attR1 site, the chloramphenicol resistance gene, the ccdB gene, the attR2 site, and the V5 epitope were replaced by multiple cloning sites (SpeI, SwaI, NheI, XhoI, PmeI, and EcoRI). The pLV7 PG construct was generated by excision of the expression-optimized Gag gene from pcoPG4 (50) and subsequent ligation of the insert into pLV7 (EF1a MCS ZeoW) using the SwaI and XhoI restriction sites. The pLV7 PG CeYFP construct was generated by excision of the expression-optimized Gag gene with a C-terminal enhanced yellow fluorescent protein (eYFP) (CeYFP) tag from pcoPG4 CeYFP (50) and subsequent ligation of the insert into pLV7 (EF1a MCS ZeoW) using the SwaI and XhoI restriction sites.…”
Section: Methodsmentioning
confidence: 99%
“…Furthermore, a PR-inactive variant (D 24 A mutation), pcziPol iPR (ncoPP iPR), based on the pcziPol packaging construct was generated. Plasmid puc2MD9 (PTV), encoding a packageable PFV vector RNA containing a spleen focus-forming virus U3 region (SFFV U3)-driven egfp marker gene expression cassette, was used as a transfer vector (37).…”
Section: Methodsmentioning
confidence: 99%
“…Plasmid pcHSRV2 (50), the pol ATG-to-CTG mutant plasmid pcHSRV2-M54 (22), the gag ATG-to-TTG mutant plasmid pcHSRV2-M78 (30), pNLS-NES (73), pNLS-NES-M90 (73), p3CANc (57), the codon-optimized gag expression plasmid pcoPG4 (69), and pEGFP (Invitrogen) have been described previously.…”
Section: Methodsmentioning
confidence: 99%